D. E. Shaw & Co., Inc. Bio Rad Laboratories, Inc. Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 16,788 shares of BIO stock, worth $5.55 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

16,788

Holding current value

$5.55 Million

% of portfolio

0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$263.97 - $344.64 $6.91 Million - $9.03 Million	-26,188 Reduced 60.94%	16,788 $5.62 Million
Q2 2024 Aug 14, 2024	SELL	$268.26 - $339.48 $978,880 - $1.24 Million	-3,649 Reduced 7.83%	42,976 $11.7 Million
Q1 2024 May 15, 2024	SELL	$304.11 - $351.99 $3.87 Million - $4.48 Million	-12,729 Reduced 21.45%	46,625 $16.1 Million
Q4 2023 Feb 14, 2024	BUY	$269.37 - $365.04 $12.7 Million - $17.2 Million	47,242 Added 390.04%	59,354 $19.2 Million
Q3 2023 Nov 14, 2023	BUY	$350.25 - $422.63 $283,352 - $341,907	809 Added 7.16%	12,112 $4.34 Million
Q2 2023 Aug 14, 2023	SELL	$359.49 - $486.4 $1.4 Million - $1.9 Million	-3,898 Reduced 25.64%	11,303 $4.29 Million
Q1 2023 May 15, 2023	SELL	$418.69 - $503.0 $14 Million - $16.9 Million	-33,557 Reduced 68.82%	15,201 $7.28 Million
Q4 2022 Feb 14, 2023	BUY	$351.71 - $456.01 $11.8 Million - $15.2 Million	33,437 Added 218.24%	48,758 $20.5 Million
Q3 2022 Nov 14, 2022	SELL	$412.59 - $563.26 $1.2 Million - $1.63 Million	-2,897 Reduced 15.9%	15,321 $6.39 Million
Q2 2022 Aug 15, 2022	SELL	$463.67 - $597.16 $4.51 Million - $5.8 Million	-9,718 Reduced 34.79%	18,218 $9.02 Million
Q1 2022 May 16, 2022	BUY	$524.57 - $735.42 $9.34 Million - $13.1 Million	17,807 Added 175.8%	27,936 $15.7 Million
Q4 2021 Feb 14, 2022	BUY	$708.84 - $794.68 $2.26 Million - $2.54 Million	3,191 Added 45.99%	10,129 $7.65 Million
Q3 2021 Nov 15, 2021	SELL	$657.71 - $825.77 $4.11 Million - $5.16 Million	-6,246 Reduced 47.38%	6,938 $5.18 Million
Q2 2021 Aug 16, 2021	BUY	$576.64 - $649.04 $4.26 Million - $4.8 Million	7,392 Added 127.62%	13,184 $8.49 Million
Q1 2021 May 17, 2021	SELL	$547.01 - $662.35 $1.16 Million - $1.41 Million	-2,122 Reduced 26.81%	5,792 $3.31 Million
Q4 2020 Feb 16, 2021	SELL	$510.68 - $643.45 $8,681 - $10,938	-17 Reduced 0.21%	7,914 $4.61 Million
Q3 2020 Nov 16, 2020	SELL	$454.43 - $535.6 $214,036 - $252,267	-471 Reduced 5.61%	7,931 $4.09 Million
Q2 2020 Aug 14, 2020	SELL	$334.87 - $493.06 $343,576 - $505,879	-1,026 Reduced 10.88%	8,402 $3.79 Million
Q1 2020 May 15, 2020	SELL	$320.01 - $409.07 $1.01 Million - $1.29 Million	-3,146 Reduced 25.02%	9,428 $3.31 Million
Q4 2019 Feb 14, 2020	SELL	$319.73 - $374.2 $2.77 Million - $3.24 Million	-8,659 Reduced 40.78%	12,574 $4.65 Million
Q3 2019 Nov 14, 2019	SELL	$304.55 - $345.24 $24.8 Million - $28.1 Million	-81,440 Reduced 79.32%	21,233 $7.07 Million
Q2 2019 Aug 14, 2019	BUY	$286.93 - $312.59 $2.15 Million - $2.34 Million	7,477 Added 7.85%	102,673 $32.1 Million
Q1 2019 May 15, 2019	SELL	$224.3 - $317.41 $30 Million - $42.5 Million	-133,900 Reduced 58.45%	95,196 $29.1 Million
Q4 2018 Feb 14, 2019	BUY	$220.1 - $309.0 $8.5 Million - $11.9 Million	38,604 Added 20.27%	229,096 $53.2 Million
Q3 2018 Nov 14, 2018	BUY	$289.28 - $326.15 $31.3 Million - $35.3 Million	108,255 Added 131.64%	190,492 $59.6 Million
Q2 2018 Aug 14, 2018	SELL	$244.1 - $303.88 $6.67 Million - $8.3 Million	-27,327 Reduced 24.94%	82,237 $23.7 Million
Q1 2018 May 15, 2018	SELL	$233.97 - $274.11 $6.23 Million - $7.3 Million	-26,638 Reduced 19.56%	109,564 $27.4 Million
Q4 2017 Feb 14, 2018	BUY	$216.94 - $271.3 $27 Million - $33.8 Million	124,666 Added 1080.67%	136,202 $32.5 Million
Q3 2017 Nov 14, 2017	BUY	$212.27 - $242.28 $2.45 Million - $2.79 Million	11,536	11,536 $2.56 Million

Others Institutions Holding BIO

# of Institutions

457

Shares Held

18.2M

Call Options Held

19.5K

Put Options Held

13.9K

View Full List

About BIO-RAD LABORATORIES, INC.

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.15B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

More about BIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account